Verus Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Verus Capital Partners's PFE Position: Q1 2026 in Review
Verus Capital Partners reduced its Pfizer (PFE) stake by 24% in Q1 2026, selling an estimated $145K and leaving 16,949 shares worth $476K. The position accounts for 0.03% of the portfolio, ranked #270.
Verus Capital Partners first reported a position in PFE in Q4 2019 and has held it in 19 quarters since. The position peaked at $920K in Q2 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Verus Capital Partners held 16,949 shares of Pfizer worth $476K as of Q1 2026.
- Verus Capital Partners sold 5,465 Pfizer shares in Q1 2026, an estimated $145K.
- Pfizer made up 0.03% of Verus Capital Partners's portfolio in Q1 2026, its #270 holding.
- Verus Capital Partners first reported a position in Pfizer in Q4 2019 and has held it in 19 quarters since.
- Verus Capital Partners's Pfizer position peaked at $920K in Q2 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.